Triazine compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9481670
APP PUB NO 20130303516A1
SERIAL NO

13981579

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel triazine compounds of formula (1), methods of their preparation, pharmaceutical compositions containing these compounds and the use of these compounds to treat proliferative disorders such as tumors and cancers and also other conditions and disorders related to or associated with dysregulation of PI3 Kinases, PI3 Kinase pathway, mTOR and/or the mTOR pathway.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PIVOT HOLDING LLC3773 HOWARD HUGHES PARKWAY SUITE 500 LAS VEGAS NV 89169-6014

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Deokar, Chandraban Rhushikesh Manesar, IN 1 2
Dugar, Sundeep San Jose, US 112 1991
Hollinger, Frank Peter Wayne, US 3 10
Kapoor, Kamal Kishore Jammu, IN 4 24
Mahajan, Dinesh Manesar, IN 18 47

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 1, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00